Patent · US Expired

A1 adenosine receptor antagonists

US6605601B2 · kind B2 · utility

2Cited by
1References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 30, 2001
Grant dateAug 12, 2003
Priority date—
Expiry dateNov 30, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I and II are disclosed as antagonists of subtype A1 adenosine receptors. These compounds are useful for treatment of various diseases and disorders, including systemic hypertension, renal failure, diabetes, asthma, an edematous condition, congestive heart failure, and renal dysfunction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.